ThirtyFiveBio
PrivateLast Round
VC Round
Apr 15, 2025
Total Funding Raised
$21.44M
Company Overview
ThirtyFiveBio is a biotechnology company developing first-in-class small-molecule inhibitors of G protein-coupled receptor 35 (GPR35) to treat severe gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThirtyFiveBio Comparables
Compare ThirtyFiveBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nxera Pharma | 73% | |
| Bristol Myers Squibb | 71% | |
| N-Zyme Biomedical | 70% |
ThirtyFiveBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 15, 2025 | ||||
| Grant | Jul 2, 2024 | ||||
| Grant | Sep 13, 2023 |
ThirtyFiveBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| AbbVie Ventures | VC Round |
| Innovate UK | Grant |
| Canaan Partners | Seed, VC Round |
| Mayewell Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2025
Raised $3.56M led by Canaan Partners
ThirtyFiveBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ThirtyFiveBio's valuation, stock price, and market status.
Is ThirtyFiveBio a public or private company?
ThirtyFiveBio is a private company.
What is the current stock price of ThirtyFiveBio?
ThirtyFiveBio is a private company with no public stock price. No recent secondary market data is available.
How much is ThirtyFiveBio worth (valuation)?
Valuation information for ThirtyFiveBio is not publicly available.
Can I buy ThirtyFiveBio stock?
ThirtyFiveBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ThirtyFiveBio's last funding round?
ThirtyFiveBio's most recent funding round was VC Round on April 15, 2025.
Who are the main investors in ThirtyFiveBio?
Key investors in ThirtyFiveBio include Innovate UK, AbbVie Ventures, Canaan Partners, Mayewell Capital.
Will ThirtyFiveBio IPO soon?
No public IPO plans have been announced for ThirtyFiveBio.
How can I track ThirtyFiveBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ThirtyFiveBio's secondary market activity and sign up for updates.